TY - JOUR AU - Geyter, C. AU - Calhaz-Jorge, C. AU - Kupka, M. S. AU - Wyns, C. AU - Mocanu, E. AU - Motrenko, T. AU - Scaravelli, G. AU - Smeenk, J. AU - Vidakovic, S. AU - Goossens, V. PY - 2018 DA - 2018// TI - ART in Europe, 2014: results generated from European registries by ESHRE JO - Hum Reprod VL - 33 UR - https://doi.org/10.1093/humrep/dey242 DO - 10.1093/humrep/dey242 ID - Geyter2018 ER - TY - JOUR AU - Foxon, G. AU - Mitchell, P. AU - Turner, N. AU - McConnell, A. AU - Kendrew, H. AU - Jenkins, J. PY - 2018 DA - 2018// TI - Bemfola® fixed dose pens potentially reduce drug wastage and associated costs of infertility treatment JO - Hum Fertil (Camb) VL - 21 UR - https://doi.org/10.1080/14647273.2017.1328131 DO - 10.1080/14647273.2017.1328131 ID - Foxon2018 ER - TY - JOUR AU - Mora, F. AU - Fauser, B. C. J. M. PY - 2017 DA - 2017// TI - Biosimilars to recombinant human FSH medicines: comparable efficacy and safety to the original biologic JO - Reprod Biomed Online VL - 35 UR - https://doi.org/10.1016/j.rbmo.2017.03.020 DO - 10.1016/j.rbmo.2017.03.020 ID - Mora2017 ER - TY - STD TI - Quintero LA, Merino VV, de la Fuente Bitaine L, Olivares Vela RO, Rayward J, Torres Afonso AT, Báez Quintana DB, Pinochet CA, Giménez MAG, Trías AG, Jenkins J. An evaluation by potential IVF/Donor Oocyte patients of the Use and Handling of the Bemfola® Pen compared with the Gonal-f® Pen and Puregon Pen® Revista Iberoamericana de Fertilidad y Reproducción Humana / Vol. 33 n° 3 Julio-Agosto-Septiembre 2016. ID - ref4 ER - TY - STD TI - European Medicines Agencies (EMA) Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human follicle stimulating hormone (r-hFSH) 21 February 2013 EMA/CHMP/BMWP/671292/2010 https://www.ema.europa.eu/en/similar-biological-medicinal-products-containing-recombinant-follicle-stimulating-hormone. Accessed 13 July 2020. UR - https://www.ema.europa.eu/en/similar-biological-medicinal-products-containing-recombinant-follicle-stimulating-hormone ID - ref5 ER - TY - JOUR AU - Wolzt, M. AU - Gouya, G. AU - Sator, M. AU - Hemetsberger, T. AU - Irps, C. AU - Rettenbacher, M. PY - 2016 DA - 2016// TI - Comparison of pharmacokinetic and safety profiles between Bemfola® and Gonal-f® after subcutaneous application JO - Eur J Drug Metab Pharmacokinet VL - 41 UR - https://doi.org/10.1007/s13318-015-0257-6 DO - 10.1007/s13318-015-0257-6 ID - Wolzt2016 ER - TY - JOUR AU - Rettenbacher, M. AU - Andersen, A. N. AU - Garcia-Velasco, J. A. AU - Sator, M. AU - Barri, P. AU - Lindenberg, S. AU - Ven, K. AU - Khalaf, Y. AU - Bentin-Ley, U. AU - Obruca, A. AU - Tews, G. AU - Schenk, M. AU - Strowitzki, T. AU - Narvekar, N. AU - Sator, K. AU - Imthurn, B. PY - 2015 DA - 2015// TI - A multi-Centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal-f® in women undergoing ovarian stimulation for IVF JO - Reprod BioMed Online VL - 30 UR - https://doi.org/10.1016/j.rbmo.2015.01.005 DO - 10.1016/j.rbmo.2015.01.005 ID - Rettenbacher2015 ER - TY - JOUR AU - Haynes, B. PY - 1999 DA - 1999// TI - Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving JO - BMJ VL - 319 UR - https://doi.org/10.1136/bmj.319.7211.652 DO - 10.1136/bmj.319.7211.652 ID - Haynes1999 ER - TY - STD TI - European Medicines Agencies (EMA) Network Strategy to 2020 Working together to improve health EMA/MB/151414/2015. https://www.ema.europa.eu/en/documents/other/eu-medicines-agencies-network-strategy-2020-working-together-improve-health_en.pdf. Accessed 13 July 2020. UR - https://www.ema.europa.eu/en/documents/other/eu-medicines-agencies-network-strategy-2020-working-together-improve-health_en.pdf ID - ref9 ER - TY - JOUR AU - Ferraretti, A. P. AU - La, M. A. AU - Fauser, B. C. AU - Tarlatzis, B. AU - Nargund, G. AU - Gianaroli, L. PY - 2011 DA - 2011// TI - ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria JO - Hum Reprod VL - 26 UR - https://doi.org/10.1093/humrep/der092 DO - 10.1093/humrep/der092 ID - Ferraretti2011 ER - TY - BOOK PY - 2015 DA - 2015// TI - CUADERNOS DE EMBRIOLOGÍA CLÍNICA. Criterios ASEBIR de Valoración Morfológica de Ovocitos, Embriones Tempranos y Blastocitos Humanos. [3ª] ID - ref11 ER - TY - JOUR PY - 2011 DA - 2011// TI - The Istanbul Consensus Workshop on Embryo Assessment: Proceedings of an Expert Meeting JO - Hum Reprod VL - 26 UR - https://doi.org/10.1093/humrep/der037 DO - 10.1093/humrep/der037 ID - ref12 ER - TY - JOUR AU - Jenkins, J. AU - Daya, S. AU - Kremer, J. AU - Balasch, J. AU - Barratt, C. AU - Cooke, I. AU - Lawford-Davies, J. AU - Sutter, P. AU - Suikari, A. M. AU - Neulen, J. AU - Nygren, K. PY - 2004 DA - 2004// TI - European classification of infertility taskforce (ECIT) response to Habbema et al., 'Towards less confusing terminology in reproductive medicine: a proposal' JO - Hum Reprod VL - 19 UR - https://doi.org/10.1093/humrep/deh499 DO - 10.1093/humrep/deh499 ID - Jenkins2004 ER - TY - JOUR AU - Polyzos, N. P. AU - Devroey, P. PY - 2011 DA - 2011// TI - A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? JO - Fertil Steril VL - 96 UR - https://doi.org/10.1016/j.fertnstert.2011.09.048 DO - 10.1016/j.fertnstert.2011.09.048 ID - Polyzos2011 ER - TY - JOUR AU - Bozdag, G. AU - Polat, I. AU - Yarali, I. AU - Yarali, H. PY - 2017 DA - 2017// TI - Live birth rates in various subgroups of poor ovarian responders fulfilling the Bologna criteria JO - Reprod BioMed Online VL - 34 UR - https://doi.org/10.1016/j.rbmo.2017.03.009 DO - 10.1016/j.rbmo.2017.03.009 ID - Bozdag2017 ER - TY - JOUR AU - Alviggi, C. AU - Andersen, C. Y. AU - Buehler, K. AU - Conforti, A. AU - Placido, G. AU - Esteves, S. C. AU - Fischer, R. AU - Galliano, D. AU - Polyzos, N. P. AU - Sunkara, S. K. AU - Ubaldi, F. M. AU - Humaidan, P. PY - 2016 DA - 2016// TI - Poseidon group (patient-oriented strategies encompassing individualized oocyte number) a new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept JO - Fertil Steril VL - 105 UR - https://doi.org/10.1016/j.fertnstert.2016.02.005 DO - 10.1016/j.fertnstert.2016.02.005 ID - Alviggi2016 ER - TY - JOUR AU - Haahr, T. AU - Esteves, S. C. AU - Humaidan, P. PY - 2018 DA - 2018// TI - Poor definition of poor-ovarian response results in misleading clinical recommendations JO - Hum Reprod VL - 33 UR - https://doi.org/10.1093/humrep/dey059 DO - 10.1093/humrep/dey059 ID - Haahr2018 ER - TY - JOUR AU - Gallot, V. AU - Berwanger da Silva, A. L. AU - Genro, V. AU - Grynberg, M. AU - Frydman, N. AU - Fanchin, R. PY - 2012 DA - 2012// TI - Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the follicular output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome JO - Hum Reprod VL - 27 UR - https://doi.org/10.1093/humrep/der479 DO - 10.1093/humrep/der479 ID - Gallot2012 ER - TY - STD TI - Sociedad Española de Fertilidad (SEF). Informe estadístico de Técnicas de Reproducción Asistida 2017. https://cnrha.sanidad.gob.es/registros/pdf/Informe_estadisticoSEF_2017.pdf. Accessed 13 July 2020. UR - https://cnrha.sanidad.gob.es/registros/pdf/Informe_estadisticoSEF_2017.pdf ID - ref19 ER - TY - STD TI - ESHRE Guideline on ovarian stimulation for IVF/ICSI October 2019. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Ovarian-Stimulation-in-IVF-ICSI. Accessed 13 July 2020. UR - https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Ovarian-Stimulation-in-IVF-ICSI ID - ref20 ER - TY - JOUR AU - Humaidan, P. AU - Chin, W. AU - Rogoff, D. AU - D’Hooghe, T. AU - Longobardi, S. AU - Hubbard, J. AU - Schertz, J. PY - 2017 DA - 2017// TI - Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders JO - Hum Reprod VL - 32 UR - https://doi.org/10.1093/humrep/dex208 DO - 10.1093/humrep/dex208 ID - Humaidan2017 ER - TY - JOUR AU - Santi, D. AU - Casarini, L. AU - Alviggi, C. AU - Simoni, M. PY - 2017 DA - 2017// TI - Efficacy of follicle-stimulating hormone (FSH) alone, FSH + luteinizing hormone, human menopausal gonadotropin or FSH + human chorionic gonadotropin on assisted reproductive technology outcomes in the “personalized” medicine era: a meta-analysis JO - Front Endocrinol VL - 8 UR - https://doi.org/10.3389/fendo.2017.00114 DO - 10.3389/fendo.2017.00114 ID - Santi2017 ER - TY - JOUR AU - Devroey, P. AU - Pellicer, A. AU - Nyboe Andersen, A. AU - Arce, J. C. PY - 2012 DA - 2012// TI - Menopur in GnRH antagonist cycles with single embryo transfer trial group. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer JO - Fertil Steril VL - 97 UR - https://doi.org/10.1016/j.fertnstert.2011.12.016 DO - 10.1016/j.fertnstert.2011.12.016 ID - Devroey2012 ER - TY - STD TI - European Directorate for the Quality of Medicines & HealthCare (EDQM). Information Leaflet Ph. Eur. Reference Standard Follitropin Chemical Reference Substance batch 2. Strasbourg; 2017. https://crs.edqm.eu/db/4DCGI/View=Y0001629. Accessed 13 July 2020. UR - https://crs.edqm.eu/db/4DCGI/View=Y0001629 ID - ref24 ER - TY - BOOK PY - 2018 DA - 2018// TI - Laboratory Report: Establishment of follitropin for peptide mapping and glycan analysis Follitropin Chemical Reference Substance 2. European Pharmacopoeia Commission PB - EDQM report CY - Strasbourg ID - ref25 ER -